Hilal Arıkoğlu

5PUBLICATIONS

11CO-AUTHORS

Epigenetics (incl. genome methylation and epigenomics)Medical devicesMolecular targetsGene expression (incl. microarray and other genome-wide approaches)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 19, 2026

CAN the variants in the THADA and ADAMST9 genes be common risk factors for type 2 diabetes development and obesity.

|Mar 14, 2026

Precise CRISPR-Mediated Editing of the <i>TGFBI</i> R555W Mutation in Patient-Derived Peripheral Blood Mononuclear Cells.

Burak Dagdelen, Hilal Arikoglu, Dudu Erkoc-Kaya

|Feb 23, 2024

Juglone-ascorbate treatment enhances reactive oxygen species mediated mitochondrial apoptosis in pancreatic cancer.

Dudu Erkoc-Kaya, Hilal Arikoglu, Ebru Guclu

|Jun 12, 2021

Type 2 diabetes is associated with the MTNR1B gene, a genetic bridge between circadian rhythm and glucose metabolism, in a Turkish population.

Hilal Arikoglu, Dudu Erkoc-Kaya, Suleyman Hilmi Ipekci

|May 06, 2020

Investigation of TGFBI (transforming growth factor beta-induced) Gene Mutations in Families with Granular Corneal Dystrophy Type 1 in the Konya Region.

Fatma Malkondu, Hilal Arıkoğlu, Dudu Erkoç Kaya

Pageof 1

Frequent Collaborators

Dudu Erkoc-Kaya

Banu Bozkurt

Ebru Guclu

Duygu Dursunoglu

Esma Menevse

Burak Dagdelen

Fatma Gokturk

Funda Iscioglu

Suleyman Hilmi Ipekci

1 joint publications

Fatma Malkondu

Frequent Collaborators

Dudu Erkoc-Kaya

Banu Bozkurt

Ebru Guclu

Duygu Dursunoglu